tirzepatide cardiovascular risk of major adverse events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist for type 2 diabetes: A systematic review and meta-analysis Cardiovascular outcomes of semaglutide and

Electrolyte Balance : Our treatment replenishes critical electrolytes like sodium and potassium, which are essential for maintaining proper body function

Animal studies have demonstrated that GLP-1 receptor activation can reduce neuroinflammation, decrease oxidative stress, and promote neuronal survival in models of neurodegenerative disease

It is important to recognize that clinical trials may have limited power to detect small increases in risk for specific rare cancer types, and longer-term observational studies will continue to provide important safety information

Medical weight loss can be effective when it combines evidence-based treatment with individualized clinical guidance

A reasonable discontinuation protocol involves reducing dose by one tier every 4 to 6 weeks while intensifying dietary control and physical activity